renamed from Sumitomo Dainippon Pharma to Sumitomo Pharma. Operating without a sales foothold in North America, then-Sumitomo Dainippon Pharma acquired NASDAQ-traded...
10 KB (777 words) - 04:16, 10 June 2024
with Saudi Aramco. Sumitomo Pharmaceuticals and Dainippon Pharmaceuticals merged to form Dainippon Sumitomo Pharma. 2007: Sumitomo Chemical acquired the...
9 KB (821 words) - 08:48, 3 April 2024
standalone subsidiary of Sumitomo Pharma of Japan (then known as Sumitomo Dainippon Pharma). In April 2023, Sumitomo Pharma announced the combination...
8 KB (684 words) - 22:18, 3 June 2024
antidepressant medication used in Japan and China, where it is marketed by Dainippon Sumitomo Pharma. It is a member of the azapirone class of drugs and is closely...
14 KB (1,206 words) - 08:09, 17 February 2024
Nihon Keizai Shimbun - Otemae Capcom - Uchihiranomachi Daimaru Dainippon Sumitomo Pharma - Dojomachi Iwatani Corporation - Hommachi JEX Co., Ltd. - Jekusu...
17 KB (1,149 words) - 02:55, 27 July 2024
discovered by Uno and colleagues in 1972 and launched by Dainippon Sumitomo Pharma (formerly Dainippon Pharmaceutical) in 1989 as Excegran in Japan. It was...
24 KB (2,038 words) - 06:46, 24 May 2024
in Egypt, and Novonorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.[failed verification] Repaglinide is an oral medication used in...
10 KB (990 words) - 13:31, 19 December 2023
drug in the United States. In 2007, Neurocrine partnered with Dainippon Sumitomo Pharma to develop and commercialize indiplon in Japan. The deal paid...
15 KB (1,289 words) - 13:20, 12 June 2024
develop OCA outside Japan and China, where it is licensed to Dainippon Sumitomo Pharma. The natural bile acid chenodeoxycholic acid was identified in...
19 KB (1,825 words) - 22:02, 12 July 2024
antipsychotic of the azapirone family. It was introduced in Japan by Dainippon Sumitomo Pharma in 2001 for the treatment of schizophrenia and acute cases of...
14 KB (1,253 words) - 23:30, 14 September 2024